ClearPoint Neuro, Inc. — Director's Dealing 2021

Jul 16, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ClearPoint Neuro, Inc. (CLPT)
CIK: 0001285550
Period of Report: 2021-07-15

Reporting Person: FALLON LYNNETTE C (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-07-15	Common Stock	A	3586	—	Acquired	3586	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-07-15	Stock Options (right to buy)	$16.73	A	7172	Acquired	2031-07-15	Common Stock (7172)	Direct

Footnotes

F1: The shares are restricted stock and will vest in full on the first anniversary of the grant date.

F2: The shares subject to this option will vest in full on the first anniversary of the grant date.